We observed that TP53/ARID1A co-mutation rates were slightly higher in metastatic tumors than in primary tumors (one-tailed Fisher’s exact test, OR = 1.20, p = 0.045) (S13C Fig). This evidence concerns the gene TP53 and metastatic neoplasm.